142 related articles for article (PubMed ID: 6133658)
1. Plasma calcitonin and ACTH responses to lysine vasopressin, calcium and pentagastrin in a patient with medullary thyroid carcinoma associated with Cushing's syndrome.
Shimatsu A; Kato Y; Tanaka I; Nakai Y; Fukunaga M; Imura H
Clin Endocrinol (Oxf); 1983 Feb; 18(2):119-25. PubMed ID: 6133658
[TBL] [Abstract][Full Text] [Related]
2. Concomitant secretion of calcitonin, beta-endorphin and ACTH from medullary thyroid carcinoma in vivo and in vitro.
Lamberts SW; Hackeng WH; Visser TJ
Eur J Cancer Clin Oncol; 1982 Mar; 18(3):253-60. PubMed ID: 6284516
[TBL] [Abstract][Full Text] [Related]
3. Pituitary ACTH dependent Cushing's syndrome due to ectopic production of a bombesin-like peptide by a medullary carcinoma of the thyroid.
Howlett TA; Price J; Hale AC; Doniach I; Rees LH; Wass JA; Besser GM
Clin Endocrinol (Oxf); 1985 Jan; 22(1):91-101. PubMed ID: 2983908
[TBL] [Abstract][Full Text] [Related]
4. Medullary thyroid carcinoma: ectopic production of peptides with ACTH-like, corticotrophin releasing factor-like and prolactin production-stimulating activities.
Birkenhäger JC; Upton GV; Seldenrath HJ; Krieger DT; Tashjian AH
Acta Endocrinol (Copenh); 1976 Oct; 83(2):280-92. PubMed ID: 184633
[TBL] [Abstract][Full Text] [Related]
5. Cushing's syndrome caused by ACTH- and calcitonin-secreting medullary carcinoma of the thyroid.
Melvin KE; Tashjian AH; Cassidy CE; Givens JR
Metabolism; 1970 Oct; 19(10):831-8. PubMed ID: 4319120
[No Abstract] [Full Text] [Related]
6. Dissociation and association between calcitonin and adrenocorticotropin secretion.
Lamberts SW; Hackeng WH; Visser TJ
J Clin Endocrinol Metab; 1980 Mar; 50(3):565-8. PubMed ID: 6244325
[No Abstract] [Full Text] [Related]
7. Plasma ACTH and cortisol responses to TRF, vasopressin or hypoglycemia in cushing's disease and nelson's syndrome.
Krieger DT; Luria M
J Clin Endocrinol Metab; 1977 Feb; 44(2):361-8. PubMed ID: 190254
[TBL] [Abstract][Full Text] [Related]
8. Cushing's syndrome due to medullary thyroid carcinoma: diagnosis by proopiomelanocortin messenger ribonucleic acid in situ hybridization.
Smallridge RC; Bourne K; Pearson BW; Van Heerden JA; Carpenter PC; Young WF
J Clin Endocrinol Metab; 2003 Oct; 88(10):4565-8. PubMed ID: 14557423
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules.
Rieu M; Lame MC; Richard A; Lissak B; Sambort B; Vuong-Ngoc P; Berrod JL; Fombeur JP
Clin Endocrinol (Oxf); 1995 May; 42(5):453-60. PubMed ID: 7621562
[TBL] [Abstract][Full Text] [Related]
10. [Cushing's syndrome caused by paraneoplastic ACTH secretion 11 years after occurence of a medullary thyroid carcinoma].
von Mach MA; Kann P; Piepkorn B; Bruder S; Beyer J
Dtsch Med Wochenschr; 2002 Apr; 127(16):850-2. PubMed ID: 11961702
[TBL] [Abstract][Full Text] [Related]
11. Secretion of adrenocorticotropin, beta-endorphin and calcitonin by cultured medullary thyroid carcinoma cells. Effects of synthetic corticotropin-releasing factor and lysine vasopressin.
Oosterom R; Verleun T; Bruining HA; Hackeng WH; Lamberts SW
Acta Endocrinol (Copenh); 1986 Sep; 113(1):65-72. PubMed ID: 3020852
[TBL] [Abstract][Full Text] [Related]
12. Cushing's syndrome in medullary thyroid carcinoma.
Mure A; Gicquel C; Abdelmoumene N; Tenenbaum F; Francese C; Travagli JP; Gardet P; Schlumberger M
J Endocrinol Invest; 1995 Mar; 18(3):180-5. PubMed ID: 7615903
[TBL] [Abstract][Full Text] [Related]
13. Concomitant falls of plasma cortisol and ACTH levels in a case of Cushing's disease during treatment with trilostane.
Nomura K; Demura H; Imaki T; Miyagawa M; Ono M; Yano T; Shizume K
Acta Endocrinol (Copenh); 1984 Jan; 105(1):93-8. PubMed ID: 6320567
[TBL] [Abstract][Full Text] [Related]
14. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
[TBL] [Abstract][Full Text] [Related]
15. Plasma ACTH-response to the corticotropin releasing factor in patients with Cushing's disease. Comparison with the lysine-vasopressin test.
Catania A; Cantalamessa L; Orsatti A; Mosca G; Minonzio F; Motta P; Reschini E; Zanussi C
Metabolism; 1984 May; 33(5):478-81. PubMed ID: 6325850
[TBL] [Abstract][Full Text] [Related]
16. The detection of elevated plasma levels of carcinoembryonic antigen in patients with suspected or established medullary thyroid carcinoma.
Wells SA; Haagensen DE; Linehan WM; Farrell RE; Dilley WG
Cancer; 1978 Sep; 42(3 Suppl):1498-503. PubMed ID: 709521
[TBL] [Abstract][Full Text] [Related]
17. Medullary carcinoma of the thyroid as a cause of Cushing's syndrome: a case with ectopic adrenocorticotropin secretion characterized by double enzyme immunostaining.
Hijazi YM; Nieman LK; Medeiros LJ
Hum Pathol; 1992 May; 23(5):592-6. PubMed ID: 1568756
[TBL] [Abstract][Full Text] [Related]
18. Assessment of cortisol and ACTH responses to the desmopressin test in patients with Cushing's syndrome and simple obesity.
Tsagarakis S; Vasiliou V; Kokkoris P; Stavropoulos G; Thalassinos N
Clin Endocrinol (Oxf); 1999 Oct; 51(4):473-7. PubMed ID: 10583315
[TBL] [Abstract][Full Text] [Related]
19. Intestinal Perforation in ACTH-Dependent Cushing's Syndrome.
Shahidi M; Phillips RA; Chik CL
Biomed Res Int; 2019; 2019():9721781. PubMed ID: 31001560
[TBL] [Abstract][Full Text] [Related]
20. Lysine vasopressin stimulation of cortisol secretion in patients with adrenocorticotropin-independent macronodular adrenal hyperplasia.
Horiba N; Suda T; Aiba M; Naruse M; Nomura K; Imamura M; Demura H
J Clin Endocrinol Metab; 1995 Aug; 80(8):2336-41. PubMed ID: 7629226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
